Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5N2B

The crystal structure of Burkholderia pseudomallei antigen and type I fimbria protein BPSL1626.

5N2B の概要
エントリーDOI10.2210/pdb5n2b/pdb
分子名称Putative fimbrial subunit type 1, 1,2-ETHANEDIOL (3 entities in total)
機能のキーワードmelioidosis, antigen, fimbrial subunit, incomplete immunoglobulin-like fold, immune system
由来する生物種Burkholderia pseudomallei
タンパク質・核酸の鎖数2
化学式量合計37877.67
構造登録者
Gourlay, L.J.,Bolognesi, M. (登録日: 2017-02-07, 公開日: 2018-01-17, 最終更新日: 2024-05-08)
主引用文献Capelli, R.,Peri, C.,Villa, R.,Nithichanon, A.,Conchillo-Sole, O.,Yero, D.,Gagni, P.,Chiari, M.,Lertmemongkolchai, G.,Cretich, M.,Daura, X.,Bolognesi, M.,Colombo, G.,Gourlay, L.J.
BPSL1626: Reverse and Structural Vaccinology Reveal a Novel Candidate for Vaccine Design againstBurkholderia pseudomallei.
Antibodies, 7:-, 2018
Cited by
PubMed Abstract: Due to significant advances in computational biology, protein prediction, together with antigen and epitope design, have rapidly moved from conventional methods, based on experimental approaches, to in silico-based bioinformatics methods. In this context, we report a reverse vaccinology study that identified a panel of 104 candidate antigens from the Gram-negative bacterial pathogen , which is responsible for the disease melioidosis. can cause fatal sepsis in endemic populations in the tropical regions of the world and treatment with antibiotics is mostly ineffective. With the aim of identifying potential vaccine candidates, we report the experimental validation of predicted antigen and type I fimbrial subunit, BPSL1626, which we show is able to recognize and bind human antibodies from the sera of infected patients and to stimulate T-lymphocytes in vitro. The prerequisite for a melioidosis vaccine, in fact, is that both antibody- and cell-mediated immune responses must be triggered. In order to reveal potential antigenic regions of the protein that may aid immunogen re-design, we also report the crystal structure of BPSL1626 at 1.9 Å resolution on which structure-based epitope predictions were based. Overall, our data suggest that BPSL1626 and three epitope regions here-identified can represent viable candidates as potential antigenic molecules.
PubMed: 31544878
DOI: 10.3390/antib7030026
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.9 Å)
構造検証レポート
Validation report summary of 5n2b
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon